sovraks1 your analysis is too simplistic, if you took the time to delve deeper you would realise ADO's cash position is more than adequate:
"ADO had a cash balance of $3.9m as at 30 Sep 2012 and quarterly cash burn of $1m. This burn rate was higher than previous quarters and can be expected to be maintained given the increased number of customers currently testing 'Mix&Go', ADO has 69 CDA's and 60 MTA's in place.
On the face of it, ADO would have to raise capital in about 9 months; however this assumption does not take into account 3 key points:
1) The $0.9m government research grant/rebate ADO historically receives in Q1 each year.
2) Expected cashflows from the "watershed" licensing agreement with eBioscience/Affymetrix. 'Mix&Go' is currently being intergrated into a number of products.
3) 2 paid "point of care" projects one with a large IVD company.
Given this, ADO should be able to avoid issuing equity until 2014. Previous management guidance has also indicated ADO would be cash sufficient until March 2014 (Q2.2012 Quarterly Activities Report)."
- Forums
- ASX - By Stock
- deal time?
sovraks1 your analysis is too simplistic, if you took the time...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.31M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.2¢ | $15.57K | 707.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 89645 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 385723 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 89645 | 0.021 |
12 | 2026809 | 0.020 |
8 | 1197237 | 0.019 |
10 | 2275012 | 0.018 |
7 | 1012891 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 385723 | 1 |
0.023 | 541962 | 4 |
0.024 | 154809 | 3 |
0.025 | 384791 | 4 |
0.026 | 158542 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online